The use of microfluorometric method for activity-guided isolation of antiplasmodial compound from plant extracts
- 275 Downloads
In vitro antiplasmodial activity of methanolic extracts of 16 medicinal plants was evaluated by fluorometric assay using PicoGreen. The IC50s, as determined by parasite DNA concentration, ranged from <11 to >200 and <13 to >200 μg/ml for Plasmodium falciparum 3D7 and K1, respectively; and the most active extracts were those from Anogeissus leiocarpus and Terminalia avicennoides (<11–≥14 μg/ml). Aqueous, butanolic, ethyl acetate, and methanolic fractions of these two extracts revealed butanolic fraction to have a relatively better activity (IC50, 10–12 μg/ml). Activity-guided chromatographic separation of the butanolic fraction on Sephadex LH-20 followed by nuclear magnetic resonance and correlation high-performance liquid chromatography revealed the presence of known hydrolysable tannins and some related compounds—castalagin, ellagic acid, flavogallonic acid, punicalagin, terchebulin, and two other fractions. The IC50s of all these compounds ranged between 8–21 μg/ml (8–40 μM) against both the strains. Toxicity assay with mouse fibroblasts showed all the extracts and isolated compounds to have IC50 ≥ 1500 μg/ml, except for Momordica balsamina with <1500 μg/l. All the extracts and isolated compounds did not affect the integrity of human erythrocyte membrane at the observed IC50s. However, adverse effects manifest in a concentration-dependent fashion (from IC50 ≥ 500 μg/ml).
KeywordsMalaria Tannin Artemisinin Ellagic Acid Hydrolysable Tannin
This work was supported by Japanese Society for the Promotion of Science (JSPS). MNS is a JSPS fellow (ID#: 05166) and wish to thank, Dr. Haruna Danwanka, Mallam Farouq and Sabo Miri of Abuabakar Tafawa Balewa University, Bauchi, Nigeria; for their cooperation during the crude extract preparations and Dr. Toshihide Mitamura of Research Institute International Medical Center of Japan, Tokyo for the supply of the P. falciparum strains and his useful comment on the work and manuscript.
- Bruce-Chwatt LJ (1988) Cinchona and its alkaloids: 350 years. NY State J Med 88:318–322Google Scholar
- Fleming LW (1999) A medical bouquet. Poppies, cinchona and willow. Scottish Med J 44:176–179Google Scholar
- Kamtchouing P, Kahpui SM, Djomeni Dzeufiet PD, Tedong LEA, Asongalem EA, Dimo T (2006) Anti-diabetic activity of methanol/methylene chloride stem bark extracts of Terminalia superba and Canarium schweinfurthii on streptozotocin-induced diabetic rats. J Ethnopharmacol 104:306–309PubMedCrossRefGoogle Scholar
- Lin T, Nonaka G, Nishioka I, Ho F (1990) Tannins and related compounds.CII. Structures of terchebulin, an ellagitannin having a novel tetraphenylcarboxylic acid (terchebulic acid) moiety, and biogenetically related tannins from Terminalia chebula RETZ. Chem Pharm Bull 38:3004–3008Google Scholar
- Phillipson JD, Wright CW, Kirby GC, Warhurst DC (1993) Tropical plants as sources of antiprotozoal agents. Recent Adv Phytochem 27:1–40Google Scholar
- Tanaka T, Nonaka G, Nishioka I (1986a) Tannins and related compounds. XLI. Isolation and characterization of novel ellagitannins, punicacorteins A, B, C and D, and punigluconin from the bark of Punica granatum L. Chem Pharm Bull 34:656–663Google Scholar
- Tanaka T, Nonaka G, Nishioka I (1986b) Tannins and related compounds. XLII. Isolation and characterization of four new hydrolyzable tannins, terflavins A and B, tergallagin and tercatain from the leaves of Terminalia catappa L. Chem Pharm Bull 4:1039–1049Google Scholar
- Tanaka T, Ueda N, Shinohara H, Nonaka G, Fujioka T, Mihashi K, Kouno I (1996) C-glycosidic ellagitannin metabolites in the heartwood of Japanese chestnut tree (Castanea crenata Sieb. et Zucc.). Chem Pharm Bull 44:2236–2242Google Scholar
- WHO (2003) Fact sheet N°134, Revised May, 2003. Traditional medicineGoogle Scholar
- Yolanda C, Liuris H, Jose G, Luis C, Todd LC, Phyllis DC, Thomas AK, Luzi R, Eduardo O-B (2004) A novel DNA-based microfluorometric method to evaluate antimalarial drug activity. Am J Trop Med Hyg 70:119–124Google Scholar
- Ziegler HL, Franzyk H, Sairafianpour M, Tabatabai M, Tehrani MD, Bagherzadeh K, Hagerstrand H, Staerk D, Jaroszewski JW (2004) Erythrocyte membrane modifying agents and the inhibition of Plasmodium falciparum growth: structure–activity relationships for betulinic acid analogues. Bioorg Med Chem 12:119–127PubMedCrossRefGoogle Scholar